Synthesis and Screening of Human Monoamine Oxidase-A Inhibitor Effect of New 2-Pyrazoline and Hydrazone Derivatives
dc.contributor.author | Yelekçi, Kemal | |
dc.contributor.author | Baysal, İpek | |
dc.contributor.author | Yabanoğlu-Çiftçi, Samiye | |
dc.contributor.author | Djikic, Teodora | |
dc.contributor.author | Yelekçi, Kemal | |
dc.contributor.author | Uçar, Gülberk | |
dc.contributor.author | Ertan, Rahmiye | |
dc.date.accessioned | 2019-06-27T08:02:11Z | |
dc.date.available | 2019-06-27T08:02:11Z | |
dc.date.issued | 2015 | |
dc.department | Fakülteler, Mühendislik ve Doğa Bilimleri Fakültesi, Biyoinformatik ve Genetik Bölümü | en_US |
dc.description.abstract | A group of 35-diaryl-2-pyrazoline and hydrazone derivatives was prepared via the reaction of various chalcones with hydrazide compounds in ethanol. Twenty original compounds were synthesized. Ten of these original compounds have a pyrazoline structure nine of these original compounds have a hydrazone structure and one of these original compounds has a chalcone structure. Structural elucidation of the compounds was performed by IR H-1 NMR C-13 NMR mass spectral data and elemental analyses. These compounds were tested for their inhibitory activities toward the A and B isoforms of human monoamine oxidase (MAO). Except for 3k and 6c all compounds were found to be competitive reversible and selective inhibitors for either one of the isoforms (hMAO-A or MAO-B). Compounds 3k and 6c were found to be competitive reversible but non-selective MAO inhibitors. Compound 6h showed hMAO-B inhibitory activity whereas the others potently inhibited hMAO-A. Compound 5c showed higher selectivity than the standard drug moclobemide. According to the experimental K-i values compounds 6i 6d and 6a exhibited the highest inhibitory activity toward hMAO-A. The AutoDock 4.2 program was employed to perform automated molecular docking. The calculated results obtained computationally were in good agreement with the experimental values. | en_US] |
dc.identifier.citation | 20 | |
dc.identifier.doi | 10.1002/ardp.201500212 | en_US |
dc.identifier.endpage | 756 | |
dc.identifier.issn | 0365-6233 | en_US |
dc.identifier.issn | 1521-4184 | en_US |
dc.identifier.issn | 0365-6233 | |
dc.identifier.issn | 1521-4184 | |
dc.identifier.issue | 10 | |
dc.identifier.pmid | 26293971 | en_US |
dc.identifier.scopus | 2-s2.0-84942987491 | en_US |
dc.identifier.scopusquality | Q2 | |
dc.identifier.startpage | 743 | en_US |
dc.identifier.uri | https://hdl.handle.net/20.500.12469/569 | |
dc.identifier.uri | https://doi.org/10.1002/ardp.201500212 | |
dc.identifier.volume | 348 | en_US |
dc.identifier.wos | WOS:000362565600006 | en_US |
dc.identifier.wosquality | N/A | |
dc.institutionauthor | Yelekçi, Kemal | en_US |
dc.language.iso | en | en_US |
dc.publisher | Wiley-VCH Verlag GmbH | en_US |
dc.relation.journal | Archiv Der Pharmazie | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | 2-Pyrazoline | en_US |
dc.subject | Hydrazone | en_US |
dc.subject | MAO inhibitors | en_US |
dc.subject | Molecular docking | en_US |
dc.title | Synthesis and Screening of Human Monoamine Oxidase-A Inhibitor Effect of New 2-Pyrazoline and Hydrazone Derivatives | en_US |
dc.type | Article | en_US |
dspace.entity.type | Publication | |
relation.isAuthorOfPublication | 9407938e-3d31-453b-9199-aaa8280a66c5 | |
relation.isAuthorOfPublication.latestForDiscovery | 9407938e-3d31-453b-9199-aaa8280a66c5 |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Synthesis and Screening of Human Monoamine Oxidase-AInhibitor Effect of New 2-Pyrazoline and Hydrazone Derivatives.pdf
- Size:
- 1.23 MB
- Format:
- Adobe Portable Document Format
- Description: